CLINICAL_TRIALS
trial_result
· 2021-07-12
Clinical Trial Update: Dose Finding, Efficacy and Safety of BI 655064 in Patients With Active Lupus Nephritis [Phase 2]
Summary
A Phase 2 dose-finding study of BI 655064 in patients with active lupus nephritis has been completed, with results on efficacy and safety reported.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Lupus Nephritis | Phase 2 | Status: COMPLETED | Results posted: 2021-07-12